Aiming to explore a potential link between irisin and obesity in human breast malignancy, we investigated potential correlations of irisin levels with body mass index (BMI) and with levels of the adipokines leptin, adiponectin and resistin in breast cancer patients. Here, ADIPOQ is linked to breast cancer.